Main > ONCOLOGY (**) > GEJ Cancer MET or R PD-L1+ *** > Treatment > USA. B. PD-1 Binding MAb

---

USA. B. PD-1 Binding MAb's subsections
(*) EU CE Mark Date: 2021. 07.30
adjuvant treat.>
Company
Generic Name: nivolumab
TradeMark

USA. B. PD-1 Binding MAb's products
This section has no products